(Q34712622)

4 August 2017

title

Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway (English)

1 reference

4 August 2017

0 references

Neil Herring

1

1 reference

4 August 2017

Michael N Lokale

2

1 reference

4 August 2017

Edward J Danson

3

1 reference

4 August 2017

Daniel A Heaton

4

1 reference

4 August 2017

David J Paterson

5

1 reference

4 August 2017

publication date

11 October 2007

1 reference

Journal of Molecular and Cellular Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

44

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

477-485

1 reference

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Elevation of plasma neuropeptide Y levels in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Sites at which neuropeptide Y modulates parasympathetic control of heart rate in guinea pigs and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Cardiac vagal action and plasma levels of neuropeptide Y following intravenous injection in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Effects of exogenous neuropeptide Y on automaticity of isolated Purkinje fibers and atrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Receptors for neuropeptide Y: multiple subtypes and multiple second messengers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Neuropeptide Y family of hormones: receptor subtypes and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Presence of neuronal nitric oxide synthase in the suprachiasmatic nuclei of mouse and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Chelerythrine is a potent and specific inhibitor of protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

The mechanism underlying the positive inotropic effect of angiotensin II in the isolated perfused rabbit heart: a 31P NMR study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

The influence of activation or inhibition of protein kinase C on the release of radioactivity from rat isolated atria labelled with [3H]-noradrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Inhibition of acetylcholine-activated K(+) current by chelerythrine and bisindolylmaleimide I in atrial myocytes from mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

PACAP induces bradycardia in guinea-pig heart by stimulation of atrial cholinergic neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Inhibition of calcium currents in cultured myenteric neurons by neuropeptide Y: evidence for direct receptor/channel coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurons via a pertussis toxin-sensitive mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.001

10.1016/J.YJMCC.2007.10.001

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference